Devices & Diagnostics

Angeion retains interim CEO Gregg Lehman for top job

Interim CEO Gregg Lehman at Angeion (NASDAQ:ANGN) has been retained as chief executive of the the St. Paul, Minnesota, company that designs, manufactures and distributes cardiorespiratory diagnostic systems. Lehman joined the company in May following the sudden (some believe forced) departure of its previous CEO Phil Smith after just six months on the job. The previous […]

Interim CEO Gregg Lehman at Angeion (NASDAQ:ANGN) has been retained as chief executive of the the St. Paul, Minnesota, company that designs, manufactures and distributes cardiorespiratory diagnostic systems.

Lehman joined the company in May following the sudden (some believe forced) departure of its previous CEO Phil Smith after just six months on the job. The previous chief financial officer of the company William Kullback was fired in July last year.

“Gregg has demonstrated exceptional leadership at the company in a short period and has positively affected our customers, employees, business partners and shareholders,” said Mark Sheffert, chairman of the board, in a news release. “Having worked closely with Gregg at Health Fitness Corporation, I have great confidence in his skills and track record to successfully lead Angeion.”

Between 2007 and 2010, Lehman was president, CEO and director for Health Fitness Corporation, a health and fitness center management company. In December, HealthFitness named a new CEO to replace him and in that announcement the company said that Lehman was leaving the company “with plans to launch a new company focused on acquiring healthcare IT and hospital service delivery companies.”

But looks like Lehman did not take that route.

Lehman also held senior-level positions in the medical and education industries including stints as CEO of Inspiris, Inc., a health care management company; CEO of Gordon Health Solutions, Inc., which provides lifestyle and disease management programs to employers and health plans; CEO of the National Business Coalition on Health (NBCH) in Washington, D.C.; and president of Taylor University in Indiana.

At Angeion, Lehman will be charged with improving the fortunes of a company plagued by an economic downturn and a public proxy battle with activist shareholder BlueLine Partners LLC that was settled. Let’s hope his tenure is longer than Phil Smith’s six month stint at the top.